Kristina Allikmets

Kristina Allikmets has been working for Takeda Pharmaceuticals for over eight years, holding various leadership roles in the Global R&D organization, currently leading the R&D organization in the Plasma-Derived Therapies Business unit. She has broad experience in clinical drug development and taking compounds through registration process in different therapy areas. Previously in Takeda, she served as a “chief executive” of a “spin-in” company within Takeda Global R&D, to take one of Takeda’s compounds through experimental phase of development following a new working model. She was also instrumental in establishing Takeda R&D Patient Outreach team and led it for several years, building the strategy and processes for how to engage patients during drug development and to ensure that the innovative medicines could make a meaningful difference to patients’ lives in the communities they serve around the world.

Before joining Takeda, Kristina worked for eight years for Nycomed Pharma, where she served as a Chief Medical Officer for several years. Kristina has an MD and PhD from University of Tartu, Estonia, she’s trained as cardiologist and internal medicine specialist and worked in academic clinical medicine for almost 15 years before joining pharmaceutical industry.